Biotech Analysts Kluska, Agrawal & Schimmer, along with Dr. Said, Professor at the University of Wisconsin School of Medicine and Dr. Stein, at Piedmont Atlanta Hospital, discusses the recently-held AASLD Liver Meeting (relevant companies CBAY ETNB AKRO MDGL VKTX TERN HEPA DRRX PLRX ARWR) on an Analyst/Industry conference call to be held on November 17 at 10 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CBAY:
- CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CymaBay announces results from RESPONSE Phase 3 study of seladelpar
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- CymaBay price target raised to $24 from $21 at H.C. Wainwright
- CymaBay reports Q3 EPS (32c), consensus (30c)